Screener
Vor Biopharma VOR Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$1.16Miss by $0.47
EPS estimate-$0.69
Next report
Nov 12, 2026 (in 2 months)EPS estimate-$0.81
Versus estimates
Diluted EPS
FAQ
- When did Vor Biopharma report Q2 2026 earnings?
- Vor Biopharma (VOR) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Vor Biopharma's Q2 2026 revenue and EPS?
- Vor Biopharma reported eps of $-1.16 for Q2 2026.
- Did Vor Biopharma beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.69 by $0.47.
- How did Vor Biopharma's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 97.3% from $-43.60.
- Where can I find Vor Biopharma's Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001193125-26-343607) directly on SEC EDGAR. The filing index links above go to sec.gov.
